Publications by authors named "Michio Ichimura"

Claim this Profile
C
Creation of haemoglobin A1c direct oxidase from fructosyl peptide oxidase by combined structure-based site specific mutagenesis and random mutagenesis.
Noriyuki Ogawa, Takehide Kimura, Fumi Umehara, Yuki Katayama, Go Nagai, Michio Ichimura

Sci Rep· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo antitrypanosomal activitiy of two microbial metabolites, KS-505a and alazopeptin.
Aki Ishiyama, Kazuhiko Otoguro, Miyuki Namatame, Aki Nishihara, Toshiaki Furusawa, Michio Ichimura

J Antibiot (Tokyo)· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conformational significance of EH21A1-A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity.
Hideyuki Onodera, Masami Kaneko, Yuichi Takahashi, Yumiko Uochi, Jun Funahashi, Michio Ichimura

Bioorg Med Chem Lett· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of PDE4 inhibitors on cortical neurons and T-lymphocytes.
Ryo Hirose, Haruhiko Manabe, Koji Yanagawa, Etsuo Ohshima, Michio Ichimura

J Pharmacol Sci· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain.
Ryo Hirose, Haruhiko Manabe, Hiromi Nonaka, Koji Yanagawa, Kaori Akuta, Michio Ichimura

Eur J Pharmacol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YCM1008A, a novel Ca2+-signaling inhibitor, produced by Fusarium sp. YCM1008.
Fumito Koizumi, Naomi Fukumitsu, Jinrong Zhao, Ruthada Chanklan, Tokichi Miyakawa, Michio Ichimura

J Antibiot (Tokyo)· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of adenosine A3 receptor functionally humanized mice for the evaluation of the human antagonists.
Kazuya Yamano, Miho Inoue, Shigehiro Masaki, Mayumi Saki, Michio Ichimura

Biochem Pharmacol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human adenosine A(3) receptor leads to intracellular Ca(2+) mobilization but is insufficient to activate the signaling pathway via phosphoinositide 3-kinase gamma in mice.
Kazuya Yamano, Miho Inoue, Shigehiro Masaki, Mayumi Saki, Michio Ichimura

Biochem Pharmacol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two new analogues of the cytotoxic substance BE-52211 from Streptomyces sp.
Natsuki K Kubota, Shinji Ohta, Emi Ohta, Fumito Koizumi, Makoto Suzuki, Michio Ichimura

J Nat Prod· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenosine modulates the striatal GABAergic inputs to the globus pallidus via adenosine A2A receptors in rats.
Tomomi Shindou, Peter J Richardson, Akihisa Mori, Hiroshi Kase, Michio Ichimura

Neurosci Lett· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 3. Replacement of quinazoline moiety and improvement of metabolic polymorphism of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.
Kenji Matsuno, Junko Ushiki, Takashi Seishi, Michio Ichimura, Neill A Giese

J Med Chem· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Piericidins C5 and C6: new 4-pyridinol compounds produced by Streptomyces sp. and Nocardioides sp.
Natsuki K Kubota, Emi Ohta, Shinji Ohta, Fumito Koizumi, Makoto Suzuki, Michio Ichimura

Bioorg Med Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. Part 4: structure-activity relationships for substituents on the quinazoline moiety of 4-[4-(N-substituted(thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.
Kenji Matsuno, Takashi Seishi, Takao Nakajima, Michio Ichimura, Neill A Giese

Bioorg Med Chem Lett· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective inhibitors of PDGF receptor phosphorylation. 2. Synthesis, structure activity relationship, improvement of aqueous solubility, and biological effects of 4-[4-(N-substituted (thio)carbamoyl)-1-piperazinyl]-6,7-dimethoxyquinazoline derivatives.
Kenji Matsuno, Takao Nakajima, Michio Ichimura, Neill A Giese, Jin-Chen Yu

J Med Chem· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective inhibitors of platelet-derived growth factor receptor phosphorylation. 1. Synthesis, structure-activity relationship, and biological effects of a new class of quinazoline derivatives.
Kenji Matsuno, Michio Ichimura, Takao Nakajima, Keiko Tahara, Shigeki Fujiwara

J Med Chem· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presynaptic adenosine A2A receptors enhance GABAergic synaptic transmission via a cyclic AMP dependent mechanism in the rat globus pallidus.
Tomomi Shindou, Hiromi Nonaka, Peter J Richardson, Akihisa Mori, Hiroshi Kase, Michio Ichimura

Br J Pharmacol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one dihydrochloride), a new potent and selective adenosine A3 receptor antagonist.
Mayumi Saki, Hiroshi Tsumuki, Hiromi Nonaka, Junichi Shimada, Michio Ichimura

Eur J Pharmacol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis